• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. / MALLINCRODT PHARMACEUTICALS, IRELAND LTD. CELLEX SYSTEM; SYSTEM, PHOTOPHERESIS, EXTRACORPOREAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. / MALLINCRODT PHARMACEUTICALS, IRELAND LTD. CELLEX SYSTEM; SYSTEM, PHOTOPHERESIS, EXTRACORPOREAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Skin Discoloration (2074); Swelling (2091); Tingling (2171); Numbness (2415)
Event Date 10/20/2019
Event Type  Injury  
Event Description
Pulmonary emboli (pe) and deep vein thrombosis (dvt) was diagnosed in a pt receiving extracorporeal photopheresis (ecp) treatment via the cellex system for bronchiolitis obliterans syndrome (bos).The patient presented to a local emergency department on (b)(6) 2019 with one day history of left leg swelling and pain, on arrival at the ed the patient also had numbness tingling to the left leg.Denied chest pain.Denied shortness of breath.O2 sat is 99% on room air.Bp 101/64, heart rate 96, respirations 20.Good dorsalis pedis pulse in left foot.No posterior tibia palpated or dopplered.Left leg cyanotic.Patient transferred to the university medical center.Vital signs remained stable.On room air.No sob, no chest pain, no abdominal pain, no back pain.Continued to have left leg pain swelling and discoloration.Ct angiography obtained.Results below.Heparin drip started and morphine given.Later transitioned to apixaban.No history of blood clots.Patient was not on any blood thinners at the time of the dvt/pe diagnosis.Left leg swelling and symptoms started 4 - 5 days following the patient's 5th ecp treatment.- of note the patient later reported a recent trip from (b)(6) for a karate tournament (b)(6) 2019.This is a 15 hour drive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX SYSTEM
Type of Device
SYSTEM, PHOTOPHERESIS, EXTRACORPOREAL
Manufacturer (Section D)
THERAKOS, INC. / MALLINCRODT PHARMACEUTICALS, IRELAND LTD.
bedminster NJ
MDR Report Key9266128
MDR Text Key164880118
Report NumberMW5090815
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/31/2019
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
Patient Weight73
-
-